Natural Alternatives International (NAII) Competitors $3.98 -0.02 (-0.60%) Closing price 03:58 PM EasternExtended Trading$3.86 -0.12 (-2.92%) As of 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAII vs. TCRX, ADAG, CRDL, SRZN, ANRO, PLRX, EPIX, OTLK, MIST, and IMUXShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include TScan Therapeutics (TCRX), Adagene (ADAG), Cardiol Therapeutics (CRDL), Surrozen (SRZN), Alto Neuroscience (ANRO), Pliant Therapeutics (PLRX), ESSA Pharma (EPIX), Oncobiologics (OTLK), Milestone Pharmaceuticals (MIST), and Immunic (IMUX). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. Its Competitors TScan Therapeutics Adagene Cardiol Therapeutics Surrozen Alto Neuroscience Pliant Therapeutics ESSA Pharma Oncobiologics Milestone Pharmaceuticals Immunic Natural Alternatives International (NASDAQ:NAII) and TScan Therapeutics (NASDAQ:TCRX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk. Do analysts recommend NAII or TCRX? TScan Therapeutics has a consensus price target of $7.80, suggesting a potential upside of 348.28%. Given TScan Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe TScan Therapeutics is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00TScan Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, NAII or TCRX? Natural Alternatives International has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500. Comparatively, TScan Therapeutics has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Does the media favor NAII or TCRX? In the previous week, TScan Therapeutics had 23 more articles in the media than Natural Alternatives International. MarketBeat recorded 23 mentions for TScan Therapeutics and 0 mentions for Natural Alternatives International. TScan Therapeutics' average media sentiment score of 0.28 beat Natural Alternatives International's score of 0.00 indicating that TScan Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Natural Alternatives International Neutral TScan Therapeutics Neutral Do insiders and institutionals hold more shares of NAII or TCRX? 32.4% of Natural Alternatives International shares are owned by institutional investors. Comparatively, 82.8% of TScan Therapeutics shares are owned by institutional investors. 20.9% of Natural Alternatives International shares are owned by company insiders. Comparatively, 4.4% of TScan Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is NAII or TCRX more profitable? Natural Alternatives International has a net margin of -6.56% compared to TScan Therapeutics' net margin of -1,964.88%. Natural Alternatives International's return on equity of -10.34% beat TScan Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-6.56% -10.34% -5.19% TScan Therapeutics -1,964.88%-63.33%-40.19% Which has better valuation & earnings, NAII or TCRX? Natural Alternatives International has higher revenue and earnings than TScan Therapeutics. Natural Alternatives International is trading at a lower price-to-earnings ratio than TScan Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$125.48M0.20-$7.22M-$1.39-2.86TScan Therapeutics$2.82M34.92-$127.50M-$1.09-1.60 SummaryTScan Therapeutics beats Natural Alternatives International on 10 of the 16 factors compared between the two stocks. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.57M$2.49B$5.73B$9.56BDividend YieldN/A1.66%4.53%4.08%P/E Ratio-2.8622.4830.4625.16Price / Sales0.20549.05392.5787.62Price / CashN/A173.7937.0358.50Price / Book0.305.268.956.21Net Income-$7.22M$31.83M$3.26B$265.38M7 Day Performance5.46%0.82%1.06%-1.13%1 Month Performance18.33%3.71%4.31%-0.71%1 Year Performance-27.71%9.37%28.39%18.86% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives InternationalN/A$3.98-0.6%N/A-23.8%$24.57M$125.48M-2.86290Gap DownTCRXTScan Therapeutics3.2669 of 5 stars$1.69-5.9%$7.80+362.9%-71.5%$95.35M$2.82M-1.55100Analyst RevisionADAGAdagene2.9976 of 5 stars$1.97+0.5%$7.00+255.3%-20.1%$93.98M$100K0.00260News CoverageGap UpCRDLCardiol Therapeutics2.6124 of 5 stars$1.13-7.8%$8.00+611.1%-38.9%$93.34MN/A-3.2820News CoveragePositive NewsEarnings ReportAnalyst RevisionSRZNSurrozen2.7439 of 5 stars$10.84-1.8%$38.50+255.2%+57.3%$92.79M$10.65M-0.7580Positive NewsGap DownANROAlto Neuroscience1.7499 of 5 stars$3.42+0.3%$8.50+148.6%-65.9%$92.58MN/A-1.43N/ATrending NewsAnalyst ForecastAnalyst RevisionPLRXPliant Therapeutics3.562 of 5 stars$1.50-4.8%$8.19+447.7%-89.7%$91.78M$1.58M-0.4490News CoverageEPIXESSA Pharma1.4496 of 5 stars$1.92+0.3%$2.00+4.4%-63.8%$90.60MN/A-3.4250News CoveragePositive NewsOTLKOncobiologics2.0969 of 5 stars$2.66-4.2%$9.60+261.6%-66.3%$89.46MN/A-4.6820Trending NewsEarnings ReportAnalyst RevisionHigh Trading VolumeMISTMilestone Pharmaceuticals1.4481 of 5 stars$1.67-2.1%$7.00+320.4%+19.7%$89.01M$1M-1.9830IMUXImmunic2.5327 of 5 stars$0.89-8.6%$7.50+738.9%-41.4%$88.39MN/A-0.7370 Related Companies and Tools Related Companies TScan Therapeutics Competitors Adagene Competitors Cardiol Therapeutics Competitors Surrozen Competitors Alto Neuroscience Competitors Pliant Therapeutics Competitors ESSA Pharma Competitors Oncobiologics Competitors Milestone Pharmaceuticals Competitors Immunic Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAII) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access